Intracerebral Hemorrhage: Mechanisms and Therapies

Translational Stroke Research

Volumn 3, Issue SUPPL. 1, 2012, Pages 1-3

  Xi, Guohua ^a   Keep, Richard F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; GLUCOSE; HEMOSTATIC AGENT; MONOCYTE CHEMOTACTIC PROTEIN 1; NEU DIFFERENTIATION FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD BRAIN BARRIER; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CLINICAL TRIAL (TOPIC); EDITORIAL; GENETIC POLYMORPHISM; HEMATOMA; HUMAN; NEONATAL HEMORRHAGE; PRIORITY JOURNAL; THROMBOEMBOLISM;

EID: 84860875060     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-012-0189-2     Document Type: Editorial

References (32)

1. Adeoye O, Broderick JP. Advances in the management of intracerebral hemorrhage. Nat Rev Neurosci. 2010; 6(11): 593-601.
2. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010; 9(2): 167-76.
3. Rincon F, Mayer SA. Intracerebral hemorrhage: clinical overview and pathophysiologic concepts. Transl Stroke Res. 2012. doi: 10. 1007/s12975-012-0175-8.
4. Morgan T, Zuccarello M, Narayan R, Keyl P, Lane K, Hanley D. Preliminary findings of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage evacuation (MISTIE) clinical trial. Acta Neurochir - Supplement. 2008; 105: 147-51.
5. Mendelow AD, Gregson BA, Mitchell PM, Murray GD, Rowan EN, Gholkar AR. Surgical trial in lobar intracerebral haemorrhage (STICH II) protocol. Trials. 2011; 12: 124.
6. Naff N, Williams MA, Keyl PM, Tuhrim S, Bullock MR, Mayer SA, et al. Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke. 2011; 42(11): 3009-16.
7. Hanley DF. Intraventricular hemorrhage: severity factor and treatment target in spontaneous intracerebral hemorrhage. Stroke. 2009; 40(4): 1533-8.
8. Strahle J, Garton HJL, Maher CO, Muraszko KM, Keep RF, Xi G. Mechanisms of hydrocephalus after neonatal and adult intraventricular hemorrhage. Transl Stroke Res. 2012. doi: 10. 1007/s12975-012-0182-9.
9. Bouz P. Neonatal intracerebral hemorrhage: mechanisms, managements and the outcomes. Transl Stroke Res. 2012 (in press).
10. Diringer MN, Skolnick BE, Mayer SA, Steiner T, Davis SM, Brun NC, et al. Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial. Stroke. 2010; 41(1): 48-53.
11. Fisher M, Vasilevko V, Cribbs DH. Mixed cerebrovascular disease and the future of stroke prevention. Transl Stroke Res. 2012 (in press).
12. Keric N, Maier GS, Samadani U, Kallenberg K, Dehent P, Brueck W, et al. Tissue plasminogen activator induced delayed edema in experimental porcine intracranial hemorrhage: reduction with plasminogen activator inhibitor-1 administration. Transl Stroke Res. 2012 (in press).
13. Woo D, Kaushal R, Chakraborty R, Woo J, Haverbusch M, Sekar P, et al. Association of apolipoprotein E4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage. Stroke. 2005; 36(9): 1874-9.
14. Tzourio C, Arima H, Harrap S, Anderson C, Godin O, Woodward M, et al. APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology. 2008; 70(16): 1322-8.
15. Lei B, Mace B, Bellows ST, Sullivan PM, Vitek MP, Lasowitz DT, et al. Interaction between sex and apolipoprotein E genetic background in a murine model of intracerebral hemorrhage. Transl Stroke Res. 2012 (in press).
16. Valant V, Keenan BT, Anderson CD, Shulman JM, Devan WJ, Ayres AM, et al. TOMM40 in cerebral amyloid angiopathy related intracerebral hemorrhage: comparative genetic analysis with Alzheimer's disease. Transl Stroke Res. 2012. doi: 10. 1007/s12975-012-0161-1.
17. Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol. 2006; 5(1): 53-63.
18. Johnston KC, Hall CE, Kissela BM, Bleck TP, Conaway MR, Investigators G. Glucose Regulation in Acute Stroke Patients (GRASP) trial: a randomized pilot trial. Stroke. 2009; 40(12): 3804-9.
19. Feng W, Tauhid S, Goel S, Sidorov EV, Selim M. Hyperglycemia and outcome in intracerebral hemorrhage: from bedside to bench-more study is needed. Transl Stroke Res. 2012 (in press).
20. Bodmer D, Vaughan KA, Zacharia BE, Hickman ZL, Connolly ES. The molecular mechanisms that promote edema after intracerebral hemorrhage. Transl Stroke Res. 2012. doi: 10. 1007/s12975-012-0162-0.
21. Liu D, Sharp FR. Excitatory and mitogenic signaling in cell death, blood-brain barrier breakdown and bbb repair after intracerebral hemorrhage. Transl Stroke Res. 2012. doi: 10. 1007/s12975-012-0147-z.
22. Lok J, Zhao S, Leung W, Seo JH, Navaratna D, Wang X, et al. Neuregulin-1 effects on endothelial and blood-brain-barrier permeability after experimental injury. Transl Stroke Res. 2012. doi: 10. 1007/s12975-012-0157-x.
23. Yao Y, Tsirka SE. Chemokines and their receptors in intracerebral hemorrhage. Transl Stroke Res. 2012. doi: 10. 1007/s12975-012-0155-z.
24. Hammond MD, Ai Y, Sansing LH. Gr1+ macrophages and dendritic cells dominate the inflammatory infiltrate 12 hours after experimental intracerebral hemorrhage. Transl Stroke Res. 2012. doi: 10. 1007/s12975-012-0174-9.
25. Lively S, Schlichter LC. Age-related comparisons of evolution of the inflammatory response after intracerebral hemorrhage in rats. Transl Stroke Res. 2012. doi: 10. 1007/s12975-012-0151-3.
26. Loftspring MC, Johnson HL, Johnson AJ, Clark JF. Depletion of GR-1-positive cells is associated with reduced neutrophil inflammation and astrocyte reactivity after experimental intracerebral hemorrhage. Transl Stroke Res. 2012. doi: 10. 1007/s12975-012-0184-7.
27. Simard JM, Tosun C, Ivanova S, Kurland DB, Hong C, Radecki L, et al. Heparin reduces neuroinflammation and transsynaptic neuronal apoptosis in a model of subarachnoid hemorrhage. Transl Stroke Res. 2012. doi: 10. 1007/s12975-012-0166-9.
28. Sukumari-Ramesh S, Alleyne CH, Dhandapani KM. Astrogliosis: a target for intervention in intracerebral hemorrhage? Transl Stroke Res. 2012. doi: 10. 1007/s12975-012-0165-x.
29. Hasan DM, Amans M, Tihan T, Hess C, Guo Y, Cha S, et al. Ferumoxytol-enhanced MRI to image inflammation within human brain arteriovenous malformations: a pilot investigation. Transl Stroke Res. 2012 (in press).
30. Xie B, Miao P, Sun Y, Wang Y, Yang GY. Micro computed tomography for hemorrhage disruption of mouse brain vasculature. Transl Stroke Res. 2012. doi: 10. 1007/s12975-012-0164-y.
31. He Y, Karabiyikoglu M, Hua Y, Keep RF, Xi G. ischemic preconditioning attenuates brain edema after experimental intracerebral hemorrhage. Transl Stroke Res. 2012. doi: 10. 1007/s12975-012-0171-z.
32. Morgenstern LB. Treatment of intracerebral hemorrhage-is the glass half full or half empty? Transl Stroke Res. 2012. doi: 10. 1007/s12975-012-0179-4.